The DOI matches its Crossref record, with a small difference in title or year; 29 of the 29 references it cites were found in a registry or an index.
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial
Open accessAbstract
IMPORTANCE: Norepinephrine is currently recommended as the first-line vasopressor in septic shock; however, early vasopressin use has been proposed as an alternative. OBJECTIVE: To compare the effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock. DESIGN, SETTING, AND PARTICIPANTS: A factorial (2×2), double-blind, randomized clinical trial conducted in 18 general adult intensive care units in the United Kingdom between February 2013 and May 2015, enrolling adult patients who had septic shock requiring vasopressors despite fluid resuscitation within a maximum of 6 hours after the onset of shock. INTERVENTIONS: Patients were randomly allocated to vasopressin (titrated up to 0.06 U/min) and hydrocortisone (n = 101), vasopressin and placebo (n = 104), norepinephrine and hydrocortisone (n = 101), or norepinephrine and placebo (n = 103). MAIN OUTCOMES AND MEASURES: The primary outcome was kidney failure-free days during the 28-day period after randomization, measured as (1) the proportion of patients who never developed kidney failure and (2) median number of days alive and free of kidney failure for patients who did not survive, who experienced kidney failure, or both. Rates of renal replacement therapy, mortality, and serious adverse events were secondary outcomes. RESULTS: A total of 409 patients (median age, 66 years; men, 58.2%) were included in the study, with a median time to study drug administration of 3.5 hours after diagnosis of shock. The number of survivors who never developed kidney failure was 94 of 165 patients (57.0%) in the vasopressin group and 93 of 157 patients (59.2%) in the norepinephrine group (difference, -2.3% [95% CI, -13.0% to 8.5%]). The median number of kidney failure-free days for patients who did not survive, who experienced kidney failure, or both was 9 days (interquartile range [IQR], 1 to -24) in the vasopressin group and 13 days (IQR, 1 to -25) in the norepinephrine group (difference, -4 days [95% CI, -11 to 5]). There was less use of renal replacement therapy in the vasopressin group than in the norepinephrine group (25.4% for vasopressin vs 35.3% for norepinephrine; difference, -9.9% [95% CI, -19.3% to -0.6%]). There was no significant difference in mortality rates between groups. In total, 22 of 205 patients (10.7%) had a serious adverse event in the vasopressin group vs 17 of 204 patients (8.3%) in the norepinephrine group (difference, 2.5% [95% CI, -3.3% to 8.2%]). CONCLUSIONS AND RELEVANCE: Among adults with septic shock, the early use of vasopressin compared with norepinephrine did not improve the number of kidney failure-free days. Although these findings do not support the use of vasopressin to replace norepinephrine as initial treatment in this situation, the confidence interval included a potential clinically important benefit for vasopressin, and larger trials may be warranted to assess this further. TRIAL REGISTRATION: clinicaltrials.gov Identifier: ISRCTN 20769191.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Most studies were observational, and there are concerns that de-escalation is used primarily in patients who are getting better, which is why the reported improved short-term mortality should be interpreted with caution (277,279).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [279]
Experimental — accuracy not yet measuredIn the citing paper
“Although there was no difference with respect to kidney injury (RR 0.89; 95% CI 0.72–1.11), vasopressin use reduced the risk of RRT (RR 0.71; 95% CI 0.53–0.97) [354].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“There was no significant difference between the vasopressin and norepinephrine groups in 28-day mortality [30.9% vs 27.5%; RR 1.13 (95% CI 0.85–1.51).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“Several meta-analyses suggest decreased mortality in patients with a pressure- and volume-limited strategy for established ARDS [353, 354].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“In the ADRENAL [479] study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS [478] hydrocortisone was administered for seven days; in VANISH [354] 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“Since then, three large RCTs have been published [354, 478, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“The optimal dose, timing of initiation, and duration of corticosteroids remain uncertain; recent RCTs used 200 mg per day of IV hydrocortisone in divided doses [354, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,046
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun‐Buisson, C., Beale, R. J., et al. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,789
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R. P., Singer, M., Freivogel, K., Weiss, Y., Benbenishty, J. S., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,162
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924
Self-citationHigh versus low blood-pressure target in patients with septic shock.
Asfar, P., Meziani, F., Hamel, J.-F., Grelon, F., Megarbane, B., Anguel, N., Mira, J.-P., Dequin, P.-F., Gergaud, S., Weiss, N., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312173 · Cited by 1,239
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock
Landry, D. W., Levin, H. R., Gallant, E. M., Ashton, R. C., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1122 · Cited by 990
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 723
Farmacologia dei simpaticomimetici: indicazioni terapeutiche in terapia intensiva
Léone, M., & Pastène, B. (2022) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(22)46721-1
Farmacología de los simpaticomiméticos: indicaciones terapéuticas en reanimación
Léone, M., & Pastène, B. (2022) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(22)46696-5
Clinical Management of Endotoxemia: Vasoactive and Cardiostimulant Drugs
Cocci, G., d’Errico, R., Villa, G., & Romagnoli, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-18591-5_9
Heming, N., & Annane, D. (2023) · Lessons from the ICU · doi:10.1007/978-3-031-17572-5_16
Bakker, J. (2023) · Lessons from the ICU · doi:10.1007/978-3-031-17572-5_6
Precision Medicine in Septic Shock
Chiscano‐Camón, L., Ruiz‐Rodríguez, J. C., & Ferrer, R. (2023) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-031-23005-9_5
Resuscitation and Preparation of the Emergency General Surgery Patient
Waibel, B. H., & Kamien, A. (2023) · Surgical Clinics of North America · doi:10.1016/j.suc.2023.05.011
Die aktuelle Sepsisleitlinie – was müssen Sie wissen?
Kochanek, M., & David, S. (2023) · Die Innere Medizin · doi:10.1007/s00108-023-01585-z
Writing Research Protocols in Pharmacological Studies
Jagadeesh, G., & Balakumar, P. (2023) · Springer eBooks · doi:10.1007/978-981-99-1284-1_4
Principles and Management of Sepsis
Edel, A., Fuest, K. E., & Karlis, G. (2023) · Lessons from the ICU · doi:10.1007/978-3-031-36398-6_1
Estrategia integral de reanimación del paciente con sepsis y shock séptico
del Río-Carbajo, L., Olmo, J. N.-D., Fernández‐Ugidos, P., & Vidal, P. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.02.025
Dong, M., Li, S., Jiang, J., Pi, D., Li, J., Bai, X., Lu, Y., Xu, F., Li, X., & Li, J. (2024) · Research Square · doi:10.21203/rs.3.rs-3985419/v1
Vazopresszin használata szeptikus sokkos betegek ellátásában
Hajdú, E., Berhés, M., László, I. P., Oláh, Z., Fülesdi, B., & Asztalos, L. (2024) · Orvosi Hetilap · doi:10.1556/650.2024.32992
Kochanek, M., & David, S. (2024) · Wiener klinisches Magazin · doi:10.1007/s00740-024-00527-1
Antonucci, E., Bokoch, M. P., & Kothari, R. P. (2024) · doi:10.17504/protocols.io.6qpvr8dd2lmk/v1
Tamura, T., & Sasaki, J. (2023) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.112.857
Renal Problems in Neurocritical Care
Gupta, N. (2024) · Springer eBooks · doi:10.1007/978-981-99-8059-8_30
Fallo renal agudo y sepsis en el paciente oncológico.
Hidalgo, J. (2024) · Revista de la Sociedad Ecuatoriana de Nefrología Diálisis y Trasplante · doi:10.56867/66
Pharmacological modulation of cardiac function and control of blood vessel calibre
Nicholls, J., & Bertram-Ralph, E. (2024) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2024.08.002
Elsayed, M. M., Eldeeb, A. E., Tahoun, M. M., El-Wakil, H. S., & Naga, S. S. (2024) · Alexandria Journal of Medicine · doi:10.1080/20905068.2024.2393441
Forrest, K., Cooper, N., Cramp, P., & Patel, R. (2020) · Wiley eBooks · doi:10.1002/9781394322077.ch6
Efecto de los vasopresores sobre la función renal y cardíaca en pacientes con shock séptico
Daza, J. L., & Zapata-Diaz, O. E. (2024) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2024.10.006
Vasoactive Substances as Mediators of Renal Injury
Caceres, P. S., & Rossi, N. F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00105-4
1565: SHOCKINGLY VAGUE: COMPARING ADJUNCTIVE MEASURES IN SEPTIC SHOCK
Wang, H. F., Cheriyan, B., Huebner, M., Wang, S., & Sudekum, D. (2025) · Critical Care Medicine · doi:10.1097/01.ccm.0001104924.19139.7c
Teripressin Is Used in Septic Shock Still Norepinephrine?
刘, 澳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152314
García-Álvarez, R., Ramasco, F., Alonso, J. N., Mouriz, L., Rama, P., Bilbao, I., Pérez-Carbonell, A., Rodenas, M. A., Ortega, F., Vives, M., et al. (2025) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2025.501768
Selection of Vasopressors for Sepsis-Associated Acute Kidney Injury
朱, 汝. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541194
The Role of Vasopressin and the Vasopressin Type V1a Receptor Agonist Selepressin in Septic Shock
刘, 澳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551359
García-Álvarez, R., Ramasco, F., Alonso, J. N., Mouriz, L., Rama, P., Bilbao, I., Carbonell, A. P., Rodenas, M. A., Ortega, F., Vives, M., et al. (2025) · Revista Española de Anestesiología y Reanimación (English Edition) · doi:10.1016/j.redare.2025.501768
Corticosteroids—A Not-So-Novel Treatment for Sepsis-Associated AKI
Sanghavi, S. F. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.12286
A double-edged sword: a narrative review on steroids in sepsis and septic shock
Guarino, M., Luppi, F., Perna, B., Maritati, M., Contini, C., Spampinato, M. D., & GIORGIO, R. D. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-04008-z
Balík, M., Beneš, J., Černý, V., Kula, R., Matějovič, M., Říha, H., & Tencer, T. (2025) · Anesteziologie a intenzivní medicína · doi:10.36290/aim.2025.004
Cedeño, J. A., García-Olivares, P., Castañeda, G. F., Ramirez, C. T. V., Rodríguez-Pérez, A., & Muñoz, J. (2025) · Research Square · doi:10.21203/rs.3.rs-6809611/v1
Sepsis et choc septique de l’adulte
de Roquetaillade, C., Bousta, A., Muchardt, J., & Chousterman, B. G. (2025) · EMC-Anesthésie réanimation/Encyclopédie médico-chirurgicale. Anesthésie, réanimation · doi:10.1016/s0246-0289(25)47121-7
OPTPRESS or OPTPRESSIN? Authors' reply
Endo, A., Yamakawa, K., Tagami, T., Umemura, Y., & the OPTPRESS investigators (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08011-y
Evaluation of Stress Dose Hydrocortisone Tapers in Septic Shock
Gilchrist, H. E., Roginski, M. A., & Esteves, A. M. (2025) · Hospital Pharmacy · doi:10.1177/00185787251355438
Emami, E., Molaei, E., Ghazi, S. F., Sohrabi, M., & Khalili, H. (2025) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-025-00571-0
Ochoa-Robles, E., & Durán, C. A. L. (2025) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2025.08.006
Smith, K., Montealegre, R., Blough, B. A., & Kataria, V. K. (2025) · Journal of Intensive Care Medicine · doi:10.1177/08850666251364773
Bernardoni, B., Sayre, M., Roginski, M. A., Gottula, A. L., Esteves, A. M., Tschautscher, C. F., & Lauria, M. (2025) · Air Medical Journal · doi:10.1016/j.amj.2025.08.009
Distributive shock in cardiac intensive care unit patients
Singh, S. P. (2025) · Indian Heart Journal · doi:10.1016/j.ihj.2025.09.008
When should we start vasopressin in septic shock? Revisiting an old question
Muñoz, J., & Cedeño, J. A. (2025) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2025.08.007
Balík, M., Beneš, J., Černý, V., Kula, R., Matějovič, M., Říha, H., & Tencer, T. (2025) · Cor et Vasa · doi:10.33678/cor.2025.044
Early Vasopressin in Septic Shock—Promise, Paradox, and the Pursuit of Precision
Prakash, J., Saran, K., & Choudhuri, B. (2025) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-25077
Sepsis y shock séptico en adultos
de Roquetaillade, C., Bousta, A., Muchardt, J., & Chousterman, B. G. (2025) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(25)51018-6
Sepsi e shock settico dell'adulto
de Roquetaillade, C., Bousta, A., Muchardt, J., & Chousterman, B. G. (2025) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(25)51071-x
[Translated article] Sepsis and septic shock
Bastida, C., Lugea, A. E., Fernández-Polo, A., Moreno, F. B., Cerezuela, M. M., Chiva, E. D., García, T. B., García, M. Á. A., González, I., Albanell‐Fernández, M., et al. (2025) · Farmacia Hospitalaria · doi:10.1016/j.farma.2025.10.005 · Cited by 1
Optimum renal care in critically ill patients
Pan, S., Bell, S., & Wu, V. (2025) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001328
Yang, W., Chang, X.-L., Zhang, L., Wan, L., Cheng, Y., Zhu, Y., & Xue, F. (2025) · BMC Anesthesiology · doi:10.1186/s12871-025-03443-x
When and How Much? Steroids in Sepsis
CROSLEY, E. L., Yang, P., & Esper, A. M. (2025) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.10.004
Exploring vasopressin use in septic shock: a retrospective cohort study from Türkiye (VASCO-TURK)
Küçük, A. O., Hocek, A. B., Aydın, D., Acar, B., Pehlivanlar, E., & Küçük, M. P. (2025) · BMC Anesthesiology · doi:10.1186/s12871-025-03519-8
Inotropes and vasopressors (vasoactive drugs)
Deane, A. M., Khanna, A. K., & Myburgh, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11611-7.00026-8
Adrenocortical insufficiency in critical illness
Cohen, J., & Venkatesh, B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11611-7.00071-2
Pharmacologie des sympathomimétiques : indications thérapeutiques en réanimation
Leone, M., Ragonnet, B., & Martín, C. (2014)
Tao, X., Chen, C., Luo, W., Zhou, J., Tian, J., Yang, X., & Hou, F. F. (2021) · Figshare · doi:10.6084/m9.figshare.17204818
Teixeira, J. P., Perez Ingles, D., Barton, J., Dean, J. T., García, P., Kunkel, S. J., Sarangarm, P., Weiss, N. K., Schaich, C. L., Busse, L. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25397473
Zhong, L., Ji, X.-W., Wang, H.-L., Zhao, G.-M., Zhou, Q., & Xie, B. (2020) · Figshare · doi:10.6084/m9.figshare.13173761
Nakamura, K., Nakano, H., Ikechi, D., Mochizuki, M., Takahashi, Y., Koyama, Y., Hashimoto, H., Abe, T., Hayakawa, M., & Yamakawa, K. (2024) · Figshare · doi:10.6084/m9.figshare.26605771
Teixeira, J. P., Perez Ingles, D., Barton, J., Dean, J. T., García, P., Kunkel, S. J., Sarangarm, P., Weiss, N. K., Schaich, C. L., Busse, L. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692291
Zhong, L., Ji, X.-W., Wang, H.-L., Zhao, G.-M., Zhou, Q., & Xie, B. (2020) · Figshare · doi:10.6084/m9.figshare.13173758
Zhong, L., Ji, X.-W., Wang, H.-L., Zhao, G.-M., Zhou, Q., & Xie, B. (2020) · Figshare · doi:10.6084/m9.figshare.13173764
Teixeira, J. P., Perez Ingles, D., Barton, J., Dean, J. T., García, P., Kunkel, S. J., Sarangarm, P., Weiss, N. K., Schaich, C. L., Busse, L. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692288
Nakamura, K., Nakano, H., Ikechi, D., Mochizuki, M., Takahashi, Y., Koyama, Y., Hashimoto, H., Abe, T., Hayakawa, M., & Yamakawa, K. (2024) · Figshare · doi:10.6084/m9.figshare.26605768
Endo, A., Yamakawa, K., Tagami, T., Umemura, Y., Takahashi, K., Nagasawa, H., Araki, Y., Kojima, M., Sera, T., Yagi, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21206608
Moreno, R., Rhodes, A., Piquilloud, L., Glenn Hernández, P., Takala, J. A., Gershengorn, H. B., Tavares, M., Coopersmith, C. M., Myatra, S. N., Singer, M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603861
Leisman, D. E., Handisides, D. R., Busse, L. W., Chappell, M. C., Chawla, L. S., Filbin, M. R., Goldberg, M. B., Ham, K. R., Khanna, A. K., Ostermann, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26708750
Teixeira, J. P., Perez Ingles, D., Barton, J., Dean, J. T., García, P., Kunkel, S. J., Sarangarm, P., Weiss, N. K., Schaich, C. L., Busse, L. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25397686
Vasopressin Versus Norepinephrine in Septic Shock: The VASST Trial
Chacko, J., Chalfin, D. B., Seppelt, I., Pawar, S., & Brar, G. (2025) · Springer eBooks · doi:10.1007/978-981-95-0673-6_55
Vasopressor therapy in septic shock
Jozwiak, M., Chew, M. S., & Khanna, A. K. (2025) · Intensive and Critical Care Nursing · doi:10.1016/j.iccn.2025.104307
Timing Matters: Caution and Opportunity in Early Vasopressin for Septic Shock
Karim, H. M. R., Khandelwal, A., Atlapure, B. B., & Azeez, A. M. (2025) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-25108
Valente, M. L. S., do Carmo, H. M. O., Fernandes, B. A. D. S. A., de Oliveira, S. G., Lima, L. B., Dalto, D. J., & de Magalhães, A. C. P. S. (2025) · Panamerican Journal of Trauma Critical Care & Emergency Surgery · doi:10.5005/jp-journals-10030-1503
Comparing Vasopressin and Hydrocortisone as Adjunctive Measures in Septic Shock
Wang, H. F., Cheriyan, B., Huebner, M., Wang, S., & Sudekum, D. (2026) · Annals of Pharmacotherapy · doi:10.1177/10600280251406750
Walter, E., Ghinelli, F., Goyer, I., Léone, M., & Pirracchio, R. (2026) · Journal of Medical Economics · doi:10.1080/13696998.2026.2622854
Jiang, R., Song, X., Ma, H., Li, S., Lui, K. Y., Hu, X., Zhu, Y., Cai, C., & Tang, Z. (2026) · BMC Anesthesiology · doi:10.1186/s12871-026-03724-z
Utility of a Peripheral Intravenous Catheter for Administration of Vasopressors: A Narrative Review
Ashraf, M. H., Dasan, S. L. A. M., Zacharia, G. S., Ali, M., Hocine, F. K., Mazhar, N., Yordanka, D. S., & Khaja, M. (2026) · Cureus · doi:10.7759/cureus.105205
Basilakis, A., & Dünser, M. W. (2026) · medRxiv · doi:10.64898/2026.04.05.26350216
A new consensus framework for understanding immune dysregulation in sepsis and critical illness
Karvunidis, T. (2026) · Anesteziologie a intenzivní medicína · doi:10.36290/aim.2026.002
Effect of Body Weight on Hemodynamic Response to Vasopressin in Patients With Septic Shock
Jorgensen, E. O., Custodio, M. M., He, R., & Urias, G. A. (2026) · Annals of Pharmacotherapy · doi:10.1177/10600280261436423
Cai, X., Liu, H., & Liang, Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1735359
Urine output following vasopressin initiation in children in intensive care
Gelbart, B., MBiostat, K. Q., Ramesh, S., Veysey, A., & Carlin, J. (2026) · Intensive Care Medicine – Paediatric and Neonatal · doi:10.1007/s44253-026-00119-3
Liu, L., Shi, H., Zhang, L., & Ma, J. (2026) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s583585
Critical care in the severely burned: Organ support and management of complications
Culnan, D. M., Sherman, W. C., Chung, K. K., Sjöberg, F., & Wolf, S. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-88389-4.00035-x
Acute renal failure in association with thermal injury
Portalatin, M. E., Goverman, J. M., Fagan, S. P., & Carson, J. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-88389-4.00034-8
Optimizing Timing and Dose of Starting Norepinephrine and Vasopressin in Septic Shock
Hiroto, G., Nishikimi, M., & Shime, N. (2026) · Life · doi:10.3390/life16060913
Relationship between norepinephrine dose and outcome in septic shock: a retrospective study
Calabrò, L. A., Pasetto, M., Zorzi, S., Polato, M., Vitali, E., Faso, C., Castellani, S., Njimi, H., Donadello, K., Gottin, L., et al. (2026) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-026-00425-4
Cayford, J., Atteberry, B., Singh-Taylor, A., Retter, A., Berman, B. P., & Kelly, T. K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1796580
Inotropes and Vasopressors in Special Populations with Septic Shock: A Narrative Review
Sulaiman, K. A. A., Aldardeer, N. F., Abdulqader, M. B., Alqahtani, R., Almagthali, A., Alrashed, A., Alharthi, A. F., Al-Dosari, B. S., Nazer, L. H., Alhaidal, H. A., et al. (2026) · The SCAPE Journal for Multidisciplinary Research and Development · doi:10.4103/sjmr.sjmr_14_25
RAMIREZ, F., & Rodriguez, J. D. A. (2026) · IECCMEXICO · doi:10.64784/224
Hydrocortisone Use for Septic Shock in Patients With CKD
Dhamelia, P., Abeyagunawardene, H., Kore, R. A., Raghavan, D., Arthur, J. M., Vyas, K. S., Khandekar, N., & Jain, N. (2026) · Kidney International Reports · doi:10.1016/j.ekir.2026.106686
Montes, L. F. C., Sabas, G. S., Félix, I. S. F., & Cruz, B. E. T. (2026) · Medicina Crítica · doi:10.35366/123470
Early vasopressin in septic shock: Which evidence should we trust?
Guiotto, G. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.107045
Twichell, E., Sattler, L. A., & Reynolds, D. (2026) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001409
An International Survey of Corticosteroid Use in Septic Shock
Ho, J. C., Zamir, N., Pereira, T. V., Rochwerg, B. N., Bosch, N. A., Mazer, C. D., Kaufman, D. A., Yarnell, C. J., Law, A. C., Jivraj, N. K., et al. (2026) · CHEST Critical Care · doi:10.1016/j.chstcc.2026.100297
Premer, C., Starahs, M., Hare, J. M., & Merchant, R. C. (2026) · Research Square · doi:10.21203/rs.3.rs-10450697/v1
Whitehouse, T., Hossain, A., Bion, J., Gordon, A. C., McAuley, D. F., Lord, J. M., Perkins, G. D., Singer, M., Young, D., & Lall, R. (2025) · Efficacy and Mechanism Evaluation · doi:10.3310/wlfu6246
Self-citationFive things the intensivist cannot forget in the management of septic shock
Pontes, C. D. N., Estenssoro, E., & Machado, F. R. (2026) · Critical Care Science · doi:10.62675/2965-2774.20260360
Hour-1 Sepsis Bundle: Updated Evidence
PASCALE, G. D., Cutuli, S. L., Carelli, S., Cisterna, I., Vecchio, P. D., Franchini, E. O., Grilli, F. L., Lombardi, G., Palladini, A., Tagliamonte, A., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15156049
Metadata
- Authors
- Gordon, A. C., Mason, A. J., Thirunavukkarasu, N., Perkins, G. D., Cecconi, M., Cepkova, M., Pogson, D. G., Aya, H. D., Anjum, A., Frazier, G. J., Santhakumaran, S., Ashby, D., Brett, S. J., & for the VANISH Investigators
- Affiliations
- Imperial College London (GB)
- London School of Hygiene & Tropical Medicine (GB)
- University of Warwick (GB)
- National Health Service (GB)
- Corresponding author
- Gordon, Anthony C.
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-08-02
- Volume
- 316
- Issue
- 5
- Pages
- 509
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2489536306
- Semantic Scholar
- 0a2e8f0595aed35457448e71c5f52e2cd0ccb618
- Cited by
- 728
- References
- 29
- Citations by year
- 2026: 77 · 2025: 114 · 2024: 82 · 2023: 69 · 2022: 59 · 2021: 61 · 2020: 67 · 2019: 83 · 2018: 62 · 2017: 40 · 2016: 12
- FWCI
- 61.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- University of Brighton Repository (University of Brighton) (publishedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Warwick Research Archive Portal (University of Warwick) (submittedVersion)
- Funders
- University of Portsmouth
- Intensive Care Foundation
- University Hospital Southampton NHS Foundation Trust
- National Institute for Health and Care Research (NF-SI-0514-10139, NIHR/CS/009/007, PB-PG-0610-22350)
- Imperial College London
- Imperial College Healthcare NHS Trust
- Barts Health NHS Trust
- University Hospitals Coventry and Warwickshire NHS Trust
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- septic shock, vasopressin, norepinephrine, renal failure, acute kidney injury, vasopressor therapy, cortisol, renal replacement therapy, mortality, intensive care unit patients, fluid resuscitation, serious adverse events, 90-day outcomes
- MeSH terms
- Adult, Aged, Aged, 80 and over, Critical Care, Double-Blind Method, Drug Administration Schedule, Female, Fluid Therapy, United Kingdom, Humans, Hydrocortisone, Intensive Care Units, Male, Middle Aged, Norepinephrine, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Outcome, Renal Replacement Therapy, Renal Insufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
